MK0952 in Patients With Mild-to-Moderate Alzheimer's Disease (0952-004)(COMPLETED)

A Study to Evaluate the Effects of MK-0249 and an Alzheimer's Disease Medication on Cognitive Function in Adults With Alzheimer's Disease (MK-0249-023)

NCT00874939 ·Status: TERMINATED ·Phase: PHASE1

A Multiple Dose Study of PF-04360365 In Patients With Mild to Moderate Alzheimer's Disease

NCT00945672 ·Status: COMPLETED ·Phase: PHASE2

Efficacy Study of MPC-7869 to Treat Patients With Alzheimer's

NCT00105547 ·Status: COMPLETED ·Phase: PHASE3

A Study of MK-2214 in Adults With Mild Cognitive Impairment or Mild-to-Moderate Alzheimer's Disease (MK-2214-002)

NCT05466422 ·Status: COMPLETED ·Phase: PHASE1

Efficacy and Safety of MK-1942 as an Adjunct Therapy in Participants With Mild to Moderate Alzheimer's Disease Dementia (MK-1942-008)

NCT05602727 ·Status: TERMINATED ·Phase: PHASE2

Multiple IV Dose Study Of PF-04360365 In Patients With Mild To Moderate Alzheimer's Disease

NCT00722046 ·Status: COMPLETED ·Phase: PHASE2

Computerized Cognition Testing in Participants With Mild Alzheimer's Disease (AD) Treated With Donepezil (MK-0000-318)

NCT02064920 ·Status: COMPLETED ·Phase: PHASE2

Exploratory Study of the Effects of Peptide PMS-001 on Long-Delay Recall in Patients With Moderate to Severe Dementia

NCT06946511 ·Status: NOT_YET_RECRUITING ·Phase: PHASE1/PHASE2

Efficacy and Safety of 26-Week Treatment of AR1001 in Patients With Mild to Moderate Alzheimer's Disease

NCT03625622 ·Status: COMPLETED ·Phase: PHASE2

Phase I, Healthy Subject, Safety, Tolerability and Pharmacokinetic Study of an M1 Agonist to Treat Cognitive Impairment

NCT02291783 ·Status: COMPLETED ·Phase: PHASE1

Study to Evaluate the Efficacy and Safety of GSK239512 in Alzheimer's Disease

NCT01009255 ·Status: COMPLETED ·Phase: PHASE2

Activity of AVE1625 in Mild to Moderate Alzheimer's Patients.

NCT00380302 ·Status: COMPLETED ·Phase: PHASE1/PHASE2

Efficacy and Safety of MK-1167 in Participants With Alzheimer's Disease Dementia Taking Stable Donepezil Treatment (MK-1167-007)

NCT06285240 ·Status: COMPLETED ·Phase: PHASE1

A Phase I, Single IV Dose Of PF-04360365 In Adults With Mild To Moderate Alzheimer's Disease

NCT00455000 ·Status: COMPLETED ·Phase: PHASE1

Multiple Dose Trial of MK-4334 in Participants With Alzheimer's Clinical Syndrome (MK-4334-005)

NCT03740178 ·Status: WITHDRAWN ·Phase: PHASE1

A Study Of PF-04447943 Compared To Placebo In Subjects With Mild To Moderate Alzheimer's Disease

NCT00930059 ·Status: COMPLETED ·Phase: PHASE2

A Study of CAD106 and CNP520 Versus Placebo in Participants at Risk for the Onset of Clinical Symptoms of Alzheimer's Disease

NCT02565511 ·Status: TERMINATED ·Phase: PHASE2/PHASE3

A Study of the Safety and Tolerability of AZD5213 Effect on Sleep for Patients With Alzheimer's/Cognitive Impairment

NCT01548287 ·Status: COMPLETED ·Phase: PHASE2

A Clinical Study Evaluating the Efficacy and Safety of RPh201 Treatment in Individuals With Alzheimer's Disease With or Without Coexisting Cerebrovascular Disease

NCT03462121 ·Status: COMPLETED ·Phase: PHASE2

Sleep Trial to Prevent Alzheimer's Disease

NCT04629547 ·Status: RECRUITING ·Phase: PHASE2

Cognition Platform Study in Participants at Risk for Alzheimer's Disease (AD) (MK-0000-413)

NCT04730635 ·Status: COMPLETED ·Phase: PHASE1

An Efficacy and Safety Trial of Verubecestat (MK-8931) in Mild to Moderate Alzheimer's Disease (P07738)

NCT01739348 ·Status: TERMINATED ·Phase: PHASE2/PHASE3

Safety and Pharmacodynamics of SHR-1707 in Alzheimer's Disease Patients

NCT06199037 ·Status: TERMINATED ·Phase: PHASE2

A Phase I, Single Dose Study Of PF-04360365 In Japanese Patients With Mild To Moderate Alzheimer's Disease

NCT00607308 ·Status: COMPLETED ·Phase: PHASE1

A Randomized Study to Assess the Safety of GRF6019 Infusions in Subjects With Mild to Moderate Alzheimer's Disease

NCT03520998 ·Status: COMPLETED ·Phase: PHASE2